Dark Light
CRISPR Nobelists surrender their own European patents

CRISPR Nobelists surrender their own European patents

Technology tamfitronics A strategic move by lawyers acting for Doudna and Charpentier is the latest twist in the battleground for CRISPRCas9 technology. Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 24,99 /30days cancel any time Subscribe to this journal Receive 12 print issues and online access 214,86 […]

Read More

CRISPR screens of tumor-infiltrating NK cells identify genetic checkpoints for CAR-NK therapy

CRISPR screens of tumor-infiltrating NK cells identify genetic checkpoints for CAR-NK therapy

Technology tamfitronics Research Briefing Published: 25 June 2024 Nature Biotechnology (2024)Cite this article Subjects We use a CRISPR screening platform based on adeno-associated virus and the Sleeping Beauty transposon (AAV-SB-CRISPR) to perform in vivo CRISPR screens in primary natural killer (NK) cells across four different tumor models, and identify calcium homeostasis modulator family member 2 […]

Read More

Select your currency
USD United States (US) dollar
0
YOUR CART
  • No products in the cart.